Pacific Sun Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $360K | Sell |
5,618
-425
| -7% | -$27.2K | 0.19% | 138 |
|
|
2025
Q1 | $383K | Sell |
6,043
-250
| -4% | -$15.9K | 0.22% | 131 |
|
|
2024
Q4 | $419K | Sell |
6,293
-475
| -7% | -$31.6K | 0.23% | 122 |
|
|
2024
Q3 | $473K | Sell |
6,768
-225
| -3% | -$15.7K | 0.26% | 114 |
|
|
2024
Q2 | $453K | Sell |
6,993
-260
| -4% | -$16.9K | 0.27% | 113 |
|
|
2024
Q1 | $469K | Sell |
7,253
-265
| -4% | -$17.2K | 0.27% | 113 |
|
|
2023
Q4 | $495K | Sell |
7,518
-530
| -7% | -$34.9K | 0.31% | 101 |
|
|
2023
Q3 | $459K | Sell |
8,048
-297
| -4% | -$16.9K | 0.32% | 100 |
|
|
2023
Q2 | $524K | Buy |
+8,345
| New | +$524K | 0.35% | 91 |
|
|
2022
Q4 | $530K | Sell |
8,345
-215
| -3% | -$13.7K | 0.37% | 84 |
|
|
2022
Q3 | $505K | Sell |
8,560
-150
| -2% | -$8.85K | 0.35% | 88 |
|
|
2022
Q2 | $503K | Sell |
8,710
-150
| -2% | -$8.66K | 0.33% | 98 |
|
|
2022
Q1 | $550K | Sell |
8,860
-115
| -1% | -$7.14K | 0.3% | 100 |
|
|
2021
Q4 | $639K | Sell |
8,975
-100
| -1% | -$7.12K | 0.34% | 89 |
|
|
2021
Q3 | $679K | Buy |
+9,075
| New | +$679K | 0.39% | 79 |
|
|
2020
Q3 | $567K | Buy |
10,020
+315
| +3% | +$17.8K | 0.47% | 71 |
|
|
2020
Q2 | $565K | Buy |
9,705
+15
| +0.2% | +$873 | 0.51% | 67 |
|
|
2020
Q1 | $451K | Sell |
9,690
-160
| -2% | -$7.45K | 0.52% | 69 |
|
|
2019
Q4 | $550K | Sell |
9,850
-635
| -6% | -$35.5K | 0.48% | 73 |
|
|
2019
Q3 | $497K | Sell |
10,485
-325
| -3% | -$15.4K | 0.47% | 77 |
|
|
2019
Q2 | $579K | Buy |
+10,810
| New | +$579K | 0.55% | 64 |
|
|
2018
Q2 | $752K | Sell |
12,882
-100
| -0.8% | -$5.84K | 0.77% | 48 |
|
|
2018
Q1 | $639K | Buy |
+12,982
| New | +$639K | 0.84% | 45 |
|